Procyl Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 1 Year 11 Months
About Procyl Therapeutics
Procyl Therapeutics Private Limited (PTPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 March 2023 (One year and 11 months 2 days old ). Its registered office is in Gandhi Nagar, Gujarat, India.
The Company is engaged in the Software Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Dharmeshkumar Patel, Ripal Khamar, Vijay Thiruvenkatam, and One other member serve as directors at the Company.
Company Details
-
Location
Gandhi Nagar, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U72200GJ2023PTC139287
-
Company No.
139287
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Mar 2023
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Procyl Therapeutics?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dharmeshkumar Patel
|
Director | 17-Mar-2023 | Current |
|
Ripal Khamar
|
Director | 17-Mar-2023 | Current |
|
Vijay Thiruvenkatam
|
Director | 17-Mar-2023 | Current |
|
Sivapriya Kirubakaran
|
Director | 17-Mar-2023 | Current |
Financial Performance of Procyl Therapeutics.
Enhance accessibility to Procyl Therapeutics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Procyl Therapeutics?
Unlock access to Procyl Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Reroot Organic Private LimitedDharmeshkumar Patel is a mutual person
-
Geo-Fresh Organic Private LimitedDharmeshkumar Patel is a mutual person
-
Provi Life Sciences Private LimitedDharmeshkumar Patel and Ripal Khamar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Procyl Therapeutics?
Unlock and access historical data on people associated with Procyl Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Procyl Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Procyl Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.